View Author
aciclovir valaciclovir patient treatment lesion herpe study hospital group episode symptom infection efficacy recurrence acyclovir hsv culture hazard healing culture difference therapy ratio virus analysis percentage /ulcerative lesions regimen table result randomised valaciclovir v aciclovir lesion healing time hsv infection aciclovir groups trial safety suppressive aciclovir therapy duration pain /discomfort 500 mg experience resolution disease lesion healing length aciclovir regimen plasma clinic suppressive valaciclovir 500 mg analyses simplex /discomfort aciclovir 200 mg treatment initiation bodsworth concentration sti.bmj.com downloaded group.bmj.com valaciclovir event group.bmj.com february history endpoints sweden initiation number placebo method copenhagen /ulcerative university denmark australia sydney month prevention germany safety profile
1 Most Recent Publications
|
Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: A randomised, double blind clinical trial
(Article)
Bodsworth, N.J. Crooks, R.J. Gibb, A. Barton, S. Beylot, C. Bingham, J. Bojs, G. Cheetham, D. Curless, E. Czarnetzki, B. Davies, S. Eichmann, A. Borelli, S. Goh, B. Goldmeir, D. Gross, G. Haustein, U.F. Kinghorn, G. Lauharanta, J. Law, C. Luzzi, G. McMillan, A. Meaden, J. Vejlsgaard, G. Montemagno, U. Morel, P. Negosanti, M. Nielsen, J.E. Nilsen, A. Ong, E-K. Ortonne, J.P. Patel, R. Patten, J. Petzold, D. Paavonen, J. Rufli, T. Saari, S. Shahmanesh, M. Simpanen, A. Soltz-Szots, J. Stahl, J.P. Stolz, E. Thelin, I. Uexkull, N. von Wikstrom, A. Worm, A.M. Woolley, P. Uexkull, N. Esmann, J. Strand, A. Ingamells, A.J. |
1997-04-01
|
